Plantar fasciopathy, characterised by plantar heel pain, affects one in ten in a lifetime. Heavy-slow resistance training (HSR) is an emerging treatment, but it often takes considerable time before the effect starts to manifest. Combining HSR with a corticosteroid injection (known for its short-term pain relief) could potentially improve outcomes in both short and long term. As this combination is yet to be investigated, we aimed to evaluate the feasibility of combining HSR with a corticosteroid injection for individuals with plantar fasciopathy before investigating the efficacy in a clinical trial. We recruited 20 participants with plantar fasciopathy for this prospectively registered feasibility study ( ClinicalTrials.gov : NCT03535896). Participants received an ultrasound-guided injection and performed heel raises on a step every second day for 8 weeks. To assess participant acceptability of the combined interventions and exercise compliance, we used a 7-point Likert scale dichotomised to “unacceptable” (categories 1–2) or “acceptable” (categories 3–7) and training diaries. Greater than or equal to 10/20 had to rate the combination “acceptable”, ≥ 15/20 had to perform ≥ 20 training sessions, and ≥ 15/20 had to start exercising ≤ 7 days after injection to confirm feasibility. Eighteen out of 20 rated the combination acceptable. Five training diaries could not be retrieved. Ten out of 15 participants performed ≥ 20 training sessions, and 15/15 started exercising ≤ 7 days after injection. Based on participant acceptability and time to exercise start, combining HSR with corticosteroid injection is feasible and the efficacy should be investigated in a future trial. Due to loss of 5/20 training diaries, firm conclusions regarding exercise compliance could not be drawn. ClinicalTrials.gov , NCT03535896

中文翻译：

---

对于患有足底筋膜病的患者，除了超声引导的皮质类固醇注射外，进行重慢阻力训练：一项可行性研究


足底筋膜病以足跟痛为特征，影响一生中十分之一的人。重慢阻力训练（HSR）是一种新兴的治疗方法，但通常需要相当长的时间才能开始显现效果。将 HSR 与皮质类固醇注射（以其短期疼痛缓解而闻名）相结合可能会改善短期和长期的结果。由于这种组合尚待研究，我们的目的是在临床试验中研究疗效之前，评估将 HSR 与皮质类固醇注射联合治疗足底筋膜病患者的可行性。我们招募了 20 名患有足底筋膜病的参与者参加这项前瞻性注册可行性研究（ClinicalTrials.gov：NCT03535896）。参与者接受超声波引导注射，并每隔一天进行一次抬高台阶，持续 8 周。为了评估参与者对联合干预措施和运动依从性的可接受性，我们使用了 7 点李克特量表，分为“不可接受”（1-2 类）或“可接受”（3-7 类）和训练日记。大于或等于 10/20 的人必须将组合评为“可接受”，≥ 15/20 的人必须进行 ≥ 20 次训练，≥ 15/20 的人必须在注射后 ≤ 7 天开始锻炼，以确认可行性。 20 人中有 18 人认为该组合可接受。五本训练日记无法检索。 15 名参与者中的 10 人进行了 ≥ 20 次训练，其中 15/15 的人在注射后 ≤ 7 天开始锻炼。根据参与者的可接受性和开始运动的时间，将 HSR 与皮质类固醇注射相结合是可行的，应在未来的试验中研究其疗效。由于 5/20 训练日记丢失，无法得出有关运动依从性的明确结论。 临床试验。政府,NCT03535896